| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 362.52M | 729.26M | 800.05M | 890.31M | 965.09M | 873.22M |
| Gross Profit | 50.10M | 100.92M | 141.52M | 131.74M | 122.17M | 153.82M |
| EBITDA | -28.15M | -22.58M | 59.64M | 19.04M | 32.60M | 44.53M |
| Net Income | -86.19M | -99.69M | 35.63M | -27.99M | -3.28M | 8.21M |
Balance Sheet | ||||||
| Total Assets | 249.56M | 543.62M | 661.34M | 618.82M | 707.08M | 763.25M |
| Cash, Cash Equivalents and Short-Term Investments | 5.69M | 136.40M | 157.37M | 85.21M | 50.18M | 132.76M |
| Total Debt | 44.87M | 124.84M | 129.48M | 114.92M | 119.86M | 170.23M |
| Total Liabilities | 110.62M | 273.45M | 291.86M | 284.44M | 337.37M | 371.24M |
| Stockholders Equity | 131.25M | 262.89M | 361.62M | 327.85M | 361.71M | 383.52M |
Cash Flow | ||||||
| Free Cash Flow | 7.48M | -2.92M | 67.01M | 40.57M | -14.45M | 56.26M |
| Operating Cash Flow | 11.27M | 3.83M | 77.71M | 46.40M | -5.92M | 64.65M |
| Investing Cash Flow | -3.85M | 2.09M | -10.41M | 2.48M | -8.39M | -8.24M |
| Financing Cash Flow | -10.68M | -17.17M | -24.02M | -28.28M | -33.85M | -31.63M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | £224.47M | 16.03 | 12.51% | 7.08% | 6.18% | 4.22% | |
65 Neutral | £1.69B | 6.72 | 121.78% | 3.99% | 3.78% | 3.29% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | £26.88M | -1.20 | 63.25% | ― | -1.96% | 28.69% | |
56 Neutral | £672.76M | 8.84 | -113.93% | 1.40% | 3.94% | ― | |
52 Neutral | £50.98M | -3.03 | -43.73% | ― | -38.64% | -792.57% | |
46 Neutral | £757.95M | -6.05 | -62.07% | 4.48% | -19.03% | -318.35% |